CU Biochemistry Distinguished Professor Karolin Luger Receives 2025 AB Nexus Award in Partnership with Anschutz Collaborator
AB Nexus Announces 2025 Grant Awards with an Emphasis on Quantum-Focused Research Collaborations
Program supports multidisciplinary research partnerships between CU Anschutz and CU Boulder
The 2025 AB Nexus awardees include two quantum-focused teams, each receiving a $300,000 seed grant, and two teams of early career scientists, each receiving $75,000 in funding. More details on the teams and their research focus areas can be found below.
- Harnessing AI-Quantum Computing for Colorectal Cancer Therapies
🔬 Principal Investigators: Daniel LaBarbera, PhD (CU Anschutz), and Karolin Luger, PhD (CU Boulder)
This project uses cutting-edge quantum computing technologies, AI and the resources of the CU Anschutz Center for Drug Discovery to accelerate new treatments for colorectal cancer. By optimizing a promising class of drugs that target a key protein involved in tumor progression, the team aims to improve chemotherapy effectiveness and bring a new therapy closer to clinical trials—all while positioning Colorado as a leader in quantum-powered health innovation.
